Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient

The hepatitis C virus (HCV) is a species of diverse genotypes that infect over 170 million people worldwide, causing chronic inflammation, cirrhosis and hepatocellular carcinoma. HCV genotype 3a is common in Brazil, and it is associated with a relatively poor response to current direct-acting antiviral therapies. The HCV NS3 protein cleaves part of the HCV polyprotein, and cellular antiviral proteins. It is therefore the target of several HCV drugs. In addition to its protease activity, NS3 is also an RNA helicase. Previously, HCV present in a relapse patient was found to harbor a mutation known to be lethal to HCV genotype 1b. The point mutation encodes the amino acid substitution W501R in the helicase RNA binding site. To examine how the W501R substitution affects NS3 helicase activity in a genotype 3a background, wild type and W501R genotype 3a NS3 alleles were sub-cloned, expressed in E. coli, and the recombinant proteins were purified and characterized. The impact of the W501R allele on genotype 2a and 3a subgenomic replicons was also analyzed. Assays monitoring helicase-catalyzed DNA and RNA unwinding revealed that the catalytic efficiency of wild type genotype 3a NS3 helicase was more than 600 times greater than the W501R protein. Other assays revealed that the W501R protein bound DNA less than 2 times weaker than wild type, and both proteins hydrolyzed ATP at similar rates. In Huh7.5 cells, both genotype 2a and 3a subgenomic HCV replicons harboring the W501R allele showed a severe defect in replication. Since the W501R allele is carried as a minor variant, its replication would therefore need to be attributed to the trans-complementation by other wild type quasispecies.     

Insight into Poliovirus Genome Replication and Encapsidation Obtained from Studies of 3B-3C Cleavage Site Mutants

A poliovirus (PV) mutant (termed GG), which is incapable of producing 3AB, VPg, and 3CD proteins due to a defective cleavage site between the 3B and 3C proteins, replicated, producing 3BC-linked RNA rather than the VPg-linked RNA produced by the wild type (WT). GG PV RNA is quasi-infectious. The yield of infectious GG PV relative to replicated RNA is reduced by almost 5 logs relative to that of WT PV. Proteolytic activity required for polyprotein processing is normal for the GG mutant. 3BC-linked RNA can be encapsidated as efficiently as VPg-linked RNA. However, a step after genome replication but preceding virus assembly that is dependent on 3CD and/or 3AB proteins limits production of infectious GG PV. This step may involve release of replicated genomes from replication complexes. A pseudorevertant (termed EG) partially restored cleavage at the 3B-3C cleavage site. The reduced rate of formation of 3AB and 3CD caused corresponding reductions in the observed rate of genome replication and infectious virus production by EG PV without impacting the final yield of replicated RNA or infectious virus relative to that of WT PV. Using EG PV, we showed that genome replication and encapsidation were distinct steps in the multiplication cycle. Ectopic expression of 3CD protein reversed the genome replication phenotype without alleviating the infectious-virus production phenotype. This is the first report of a trans-complementable function for 3CD for any picornavirus. This observation supports an interaction between 3CD protein and viral and/or host factors that is critical for genome replication, perhaps formation of replication complexes.Poliovirus (PV) is the most extensively studied member of the picornavirus family and serves as a paradigm not only for picornaviruses but also for many of the nonretroviral positive strand RNA viruses (74). A schematic of the ∼7,500-nucleotide PV genome is shown in Fig. ​Fig.1A.1A. The 5′ end is linked covalently to a 22-amino-acid peptide termed VPg (virion protein genome linked) that is encoded by the 3B region of the genome. VPg and 3B are therefore used interchangeably. The 3′ end of the genome is terminated by a poly(rA) tail. Upon release of the genome into the host cell cytoplasm, genome translation is initiated by using the internal ribosome entry site. An ∼3,000-amino-acid polyprotein is produced. Complete cleavage of the polyprotein by virus-encoded proteases yields 10 proteins. The polyprotein can be divided further into three smaller polyproteins: P1, P2, and P3. P1 contains capsid proteins: VP0, VP3, and VP1. VP0 undergoes autocatalytic cleavage after genome encapsidation to produce VP4 and VP2 proteins. P2 performs host interaction functions required for robust virus multiplication, for example, shutoff of host cell translation and induction of vesicles employed for genome replication, the so-called replication complexes (RCs). P3 contains proteins that function most directly in genome replication, including the RNA-dependent RNA polymerase. Translation induces RCs, leading to genome replication. Early during infection, replicated genomes are employed as templates for translation, leading to an exponential amplification of RCs and replicated RNA. Ultimately, production of viral proteins ceases and replicated genomes are packaged. The use of RCs provides a barrier to genetic complementation; all proteins must be provided in cis, that is, produced from the RNA that they replicate.Open in a separate windowFIG. 1.PV genome organization and P3 processing pathway. (A) Schematic of the PV genome. The 5′ end of the genome is covalently linked to a peptide (VPg) encoded by the 3B region of the genome. The 3′ end contains a poly(rA) tail. Three cis-acting replication elements are known. oriL is located in 5′ NTR. oriR is located in the 3′ NTR. oriI is located in 2C-coding sequence for PV; the position of this element is virus dependent. oriI is the template for VPg uridylylation. Translation initiation employs an internal ribosome entry site (IRES). The single open reading frame encodes a polyprotein. P1 produces virion structural proteins as indicated. P2 produces proteins thought to participate in virus-host interactions required for genome replication. P3 produces proteins thought to participate directly in genome replication. Polyprotein processing is mediated by protease activity residing in 2A, 3C, and/or 3CD proteins. (B) Processing of the P3 precursor occurs by two independent pathways (60). There are major (I) and minor (II) pathways. In pathway I, processing between 3B and 3C yields 3AB and 3CD. In pathway II, processing between 3A and 3B yields 3A and 3BCD. 3BCD processing yields 3BC and 3D; 3BC processing yields 3B and 3C. Pathway II is proposed to function in genome replication and is not perturbed in the GG mutant.In addition to P3 proteins, genome replication requires three cis-acting replication elements (CREs): a cloverleaf structure located in the 5′ nontranslated region (NTR), termed oriL (left) (1, 5); a stem-loop structure located in 2C-coding sequence, termed oriI (internal) (30, 61); and a pseudoknot structure located in the 3′ NTR, termed oriR (right) (1, 40). The first step of genome replication is diuridylylation of VPg or a VPg-containing protein primer (62, 74). This reaction is templated by oriI but also requires oriL in a cell-free reaction and is catalyzed by the viral RNA-dependent RNA polymerase 3Dpol (4, 5, 11, 30, 61). In addition to the four terminal P3 cleavage products (3A, 3B, 3C, and 3D proteins) and the uncleaved P3 polyprotein, several “intermediates” are observed in infected cells (3AB, 3CD, and 3BCD proteins) (Fig. ​(Fig.1B)1B) (43, 57, 73). The major P3 cleavage pathway (I) produces 3AB and 3CD proteins; the minor P3 cleavage pathway (II) produces 3A and 3BCD proteins (Fig. ​(Fig.1B)1B) (60). In some cases, the intermediates have unique activities, specificities, and/or functions relative to their corresponding terminal cleavage products.Over the past 8 years much has been learned about oriI-templated VPg uridylylation in vitro for a variety of picornaviruses (28, 49, 53, 77, 92). However, it is still unclear whether or not VPg, 3BC(D), or 3AB is used in vivo to initiate genome replication. The VPg peptide can be uridylylated in vitro (62); however, VPg-pUpU does not chase efficiently into full-length RNA (81). 3BC(D) is uridylylated more efficiently than VPg in vitro, leading to the possibility that this precursor could be used in vivo (60). To date, 3AB has been uridylylated in vitro only in the presence of Mn²⁺ (66). In order to begin to probe the origin of VPg that is linked to picornaviral RNA, we created a PV mutant in which the cleavage site between 3B and 3C was changed from Gln-Gly to Gly-Gly (60). We refer to this mutant as GG. The GG mutation should be lethal for genome replication if use of the processed VPg peptide is absolutely required for genome replication. For the GG mutant, products of the major P3 cleavage pathway were no longer 3AB and 3CD but were now 3ABC and 3D instead. The kinetics of genome replication were reduced for the GG mutant relative to those for the wild type (WT). Surprisingly, the yield of replicated GG RNA was within an order of magnitude of that observed for WT RNA. Replicated GG RNA was then linked covalently to 3BC instead of VPg, as observed for WT PV. In spite of the substantial yield of replicated RNA, infectious virus was not recovered.We have performed a molecular characterization of the GG mutant. GG PV RNA is quasi-infectious. The low yield of virus recovery relative to replicated RNA reflects a block at a step in the PV multiplication cycle positioned after genome replication but prior to virus assembly. The existence of this step in the PV life cycle was suggested previously by Baltimore (8). Surprisingly, none of the defects associated with GG PV could be attributed to the absence of 3CD protease activity, suggesting that precursors larger than 3CD may be the primary proteases employed in vivo. All of the observed defects in GG PV multiplication were ameliorated in a pseudorevertant in which the 3B-3C cleavage site was changed from Gly-Gly to Glu-Gly. This mutant is referred to as EG. Molecular characterization of EG PV revealed for the first time a trans-complementable function for 3CD in genome replication. This observation supports a role for 3CD at a step preceding genome replication within RCs, perhaps RC formation. Our studies of EG PV confirmed the existence of a step between genome replication and virus assembly that requires 3CD and/or 3AB, thus providing compelling evidence for genome replication and genome encapsidation as distinct steps in the multiplication cycle. This study highlights the utility of polyprotein cleavage site mutants for evaluation of the viral multiplication cycle.     

Helicase-appended Topoisomerases: New Insight into the Mechanism of Directional Strand Transfer

DNA strand passage through an enzyme-mediated gate is a key step in the catalytic cycle of topoisomerases to produce topological transformations in DNA. In most of the reactions catalyzed by topoisomerases, strand passage is not directional; thus, the enzyme simply provides a transient DNA gate through which DNA transport is allowed and thereby resolves the topological entanglement. When studied in isolation, the type IA topoisomerase family appears to conform to this rule. Interestingly, type IA enzymes can carry out directional strand transport as well. We examined here the biochemical mechanism for directional strand passage of two type IA topoisomerases: reverse gyrase and a protein complex of topoisomerase IIIα and Bloom helicase. These enzymes are able to generate vectorial strand transport independent of the supercoiling energy stored in the DNA molecule. Reverse gyrase is able to anneal single strands, thereby increasing linkage number of a DNA molecule. However, topoisomerase IIIα and Bloom helicase can dissolve DNA conjoined with a double Holliday junction, thus reducing DNA linkage. We propose here that the helicase or helicase-like component plays a determinant role in the directionality of strand transport. There is thus a common biochemical ground for the directional strand passage for the type IA topoisomerases.     

A New Variant for Mathematical Analysis of Pulse Cytophotometric Data

The staining of DNA by specific fluorochromes provides a suitable method of receiving histograms in a short time by means of pulse cytometry. They represent the proliferative structure of cell populations at a high degree of statistical security. A method for quantitative determination of cell cycle phases (G_1-, S- and G₂ + M-phase) is presented which includes the fraction of cell debris in the calculation procedure. The advantages of this method are the elimination of overlapping between the fraction of debris and cell cycle phases and the quantitative determination of the fraction of cell debris offers the opportunity to get information on cytolytic potencies. Apart from the calculation of the various cell cycle phases the method provides criteria on the adaptation of mathematical analysis to primary data.     

2,4-D Resistance in a Tobacco Cell Culture Variant: Cross-Resistance to Auxins and Uptake, Efflux and Metabolism of 2,4-D

A tobacco (Nicotiana tabacum L.) variant selected as a cellline resistant to 2,4-D was found to possess cross-resistanceto auxins including IAA, naphthalene-1-acetic acid (NAA), and4-amino-3,5,6-trichloropicolinic acid (picloram). The uptakeof 2,4-D by the variant and two wild-type cell lines was essentiallylinear in relation to 2,4-D concentration, and the variant tookup 2,4-D more rapidly than the wild types. Analysis of the 2,4-Dmetabolism revealed some diversity in the metabolic patternamong the cell lines but no significant differences which couldexplain the resistance of the variant. Although the variantpossesses a much higher capacity to metabolize 2,4-D than thewild types, this is most likely a result rather than a causeof the resistance. We conclude that neither the uptake nor themetabolism is responsible for the resistance. The variant, onthe other hand, exhibited a significantly lower rate of effluxout of the cells, particularly that of free 2,4-D, than thewild types upon washing with and transfer to 2,4-D-free medium.We suggest that immobilization of 2,4-D or auxins within cellsby compart mentation may be related to but not solely responsiblefor the resistance of this tobacco cell culture variant. (Received June 18, 1984; Accepted November 21, 1984)     

A New Insertion Variant, IS231I, Isolated from a Mosquito-Specific Strain of Bacillus thuringiensis

A new insertion variant belonging to the family IS231, designated IS231I, was isolated from a mosquito larvicidal strain of the Bacillus thuringiensis serovar sotto (H4ab). IS231I was 1653 bp long and delimited by two 20 bp inverted repeats with one mismatch, flanked by two perfect 11 bp direct repeats. The element contained a single open reading frame (ORF) encoding 478 amino acids and five conserved domains: N1, N2, N3, C1, and C2. The 5′ noncoding region upstream of the ORF, presumed to form a stable stem-and-loop structure, was highly conserved in IS231I. The secondary structure conformation had a deduced free energy (ΔG = 25°C) of −17.2 kcal/mol. Comparison of the IS231I amino acid sequence with those of the 10 existing IS variants revealed that the new variant shares 89% identity with IS231A and IS231B, 65–66% with IS231M and IS231N, and 38% with IS231W.     

Substrate Specificity of and Product Formation by Muconate Cycloisomerases: an Analysis of Wild-Type Enzymes and Engineered Variants

Muconate cycloisomerases play a crucial role in the bacterial degradation of aromatic compounds by converting cis,cis-muconate, the product of catechol ring cleavage, to (4S)-muconolactone. Chloromuconate cycloisomerases catalyze both the corresponding reaction and a dehalogenation reaction in the transformation of chloroaromatic compounds. This study reports the first thorough examination of the substrate specificity of the muconate cycloisomerases from Pseudomonas putida PRS2000 and Acinetobacter “calcoaceticus” ADP1. We show that they transform, in addition to cis,cis-muconate, 3-fluoro-, 2-methyl-, and 3-methyl-cis,cis-muconate with high specificity constants but not 2-fluoro-, 2-chloro-, 3-chloro-, or 2,4-dichloro-cis,cis-muconate. Based on known three-dimensional structures, variants of P. putida muconate cycloisomerase were constructed by site-directed mutagenesis to contain amino acids found in equivalent positions in chloromuconate cycloisomerases. Some of the variants had significantly increased specificity constants for 3-chloro- or 2,4-dichloromuconate (e.g., A271S and I54V showed 27- and 22-fold increases, respectively, for the former substrate). These kinetic improvements were not accompanied by a change from protoanemonin to cis,cis-dienelactone as the product of 3-chloro-cis,cis-muconate conversion. The rate of 2-chloro-cis,cis-muconate turnover was not significantly improved, nor was this compound dehalogenated to any significant extent. However, the direction of 2-chloro-cis,cis-muconate cycloisomerization could be influenced by amino acid exchange. While the wild-type enzyme discriminated only slightly between the two possible cycloisomerization directions, some of the enzyme variants showed a strong preference for either (+)-2-chloro- or (+)-5-chloromuconolactone formation. These results show that the different catalytic characteristics of muconate and chloromuconate cycloisomerases are due to a number of features that can be changed independently of each other.     

Structural Analysis of Thermus thermophilus HB27 Mannosyl-3-phosphoglycerate Synthase Provides Evidence for a Second Catalytic Metal Ion and New Insight into the Retaining Mechanism of Glycosyltransferases

Mannosyl-3-phosphoglycerate synthase is a glycosyltransferase involved in the two-step synthetic pathway of mannosylglycerate, a compatible solute that accumulates in response to salt and/or heat stresses in many microorganisms thriving in hot environments. The three-dimensional structure of mannosyl-3-phosphoglycerate synthase from Thermus thermophilus HB27 in its binary complex form, with GDP-α-d-mannose and Mg²⁺, shows a second metal binding site, about 6 Å away from the mannose moiety. Kinetic and mutagenesis studies have shown that this metal site plays a role in catalysis. Additionally, Asp¹⁶⁷ in the DXD motif is found within van der Waals contact distance of the C1′ atom in the mannopyranose ring, suggesting its action as a catalytic nucleophile, either in the formation of a glycosyl-enzyme intermediate according to the double-displacement S_N2 reaction mechanism or in the stabilization of the oxocarbenium ion-like intermediate according to the D_N*A_Nss (S_Ni-like) reaction mechanism. We propose that either mechanism may occur in retaining glycosyltransferases with a GT-A fold, and, based on the gathered structural information, we identified an extended structural signature toward a common scaffold between the inverting and retaining glycosyltransferases.     

Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease

1. Download high-res image (200KB)
2. Download full-size image

     

Genome-Based Analysis and Gene Dosage Studies Provide New Insight into 3-Hydroxy-4-Methylvalerate Biosynthesis in Ralstonia eutropha

Recombinant Ralstonia eutropha strain PHB⁻4 expressing the broad-substrate-specificity polyhydroxyalkanoate (PHA) synthase 1 from Pseudomonas sp. strain 61-3 (PhaC1_Ps) synthesizes a PHA copolymer containing the branched side-chain unit 3-hydroxy-4-methylvalerate (3H4MV), which has a carbon backbone identical to that of leucine. Mutant strain 1F2 was derived from R. eutropha strain PHB⁻4 by chemical mutagenesis and shows higher levels of 3H4MV production than does the parent strain. In this study, to understand the mechanisms underlying the enhanced production of 3H4MV, whole-genome sequencing of strain 1F2 was performed, and the draft genome sequence was compared to that of parent strain PHB⁻4. This analysis uncovered four point mutations in the 1F2 genome. One point mutation was found in the ilvH gene at amino acid position 36 (A36T) of IlvH. ilvH encodes a subunit protein that regulates acetohydroxy acid synthase III (AHAS III). AHAS catalyzes the conversion of pyruvate to 2-acetolactate, which is the first reaction in the biosynthesis of branched amino acids such as leucine and valine. Thus, the A36T IlvH mutation may show AHAS tolerance to feedback inhibition by branched amino acids, thereby increasing carbon flux toward branched amino acid and 3H4MV biosynthesis. Furthermore, a gene dosage study and an isotope tracer study were conducted to investigate the 3H4MV biosynthesis pathway. Based on the observations in these studies, we propose a 3H4MV biosynthesis pathway in R. eutropha that involves a condensation reaction between isobutyryl coenzyme A (isobutyryl-CoA) and acetyl-CoA to form the 3H4MV carbon backbone.     

A Comprehensive Insight into Binding of Hippuric Acid to Human Serum Albumin: A Study to Uncover Its Impaired Elimination through Hemodialysis

Binding of hippuric acid (HA), a uremic toxin, with human serum albumin (HSA) has been examined by isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), molecular docking, circular dichroism (CD) and fluorescence spectroscopy to understand the reason that govern its impaired elimination through hemodialysis. ITC results shows that the HA binds with HSA at high (K_b ∼10⁴) and low affinity (K_b ∼10³) sites whereas spectroscopic results predict binding at a single site (K_b∼10³). The HA form complex with HSA that involves electrostatic, hydrogen and hydrophobic binding forces as illustrated by calculated thermodynamic parameters. Molecular docking and displacement studies collectively revealed that HA bound to both site I and site II; however, relatively strongly to the later. Esterase-like activity of HSA confirms the involvement of Arg410 and Tyr411 of Sudlow site II in binding of HA. CD results show slight conformational changes occurs in the protein upon ligation that may be responsible for the discrepancy in van’t Hoff and calorimetric enthalpy change. Furthermore, an increase in and is observed from DSC results that indicate increase in stability of HSA upon binding to HA. The combined results provide that HA binds to HSA and thus its elimination is hindered.     

Cloning, Overexpression, and Mutagenesis of the Sporobolomyces salmonicolor AKU4429 Gene Encoding a New Aldehyde Reductase, Which Catalyzes the Stereoselective Reduction of Ethyl 4-Chloro-3-Oxobutanoate to Ethyl (S)-4-Chloro-3-Hydroxybutanoate

We cloned and sequenced the gene encoding an NADPH-dependent aldehyde reductase (ARII) in Sporobolomyces salmonicolor AKU4429, which reduces ethyl 4-chloro-3-oxobutanoate (4-COBE) to ethyl (S)-4-chloro-3-hydroxybutanoate. The ARII gene is 1,032 bp long, is interrupted by four introns, and encodes a 37,315-Da polypeptide. The deduced amino acid sequence exhibited significant levels of similarity to the amino acid sequences of members of the mammalian 3β-hydroxysteroid dehydrogenase–plant dihydroflavonol 4-reductase superfamily but not to the amino acid sequences of members of the aldo-keto reductase superfamily or to the amino acid sequence of an aldehyde reductase previously isolated from the same organism (K. Kita, K. Matsuzaki, T. Hashimoto, H. Yanase, N. Kato, M. C.-M. Chung, M. Kataoka, and S. Shimizu, Appl. Environ. Microbiol. 62:2303–2310, 1996). The ARII protein was overproduced in Escherichia coli about 2,000-fold compared to the production in the original yeast cells. The enzyme expressed in E. coli was purified to homogeneity and had the same catalytic properties as ARII purified from S. salmonicolor. To examine the contribution of the dinucleotide-binding motif G₁₉-X-X-G₂₂-X-X-A₂₅, which is located in the N-terminal region, during ARII catalysis, we replaced three amino acid residues in the motif and purified the resulting mutant enzymes. Substrate inhibition of the G₁₉→A and G₂₂→A mutant enzymes by 4-COBE did not occur. The A₂₅→G mutant enzyme could reduce 4-COBE when NADPH was replaced by an equimolar concentration of NADH.     

Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis

Background

Parkinson''s disease (PD) is the most common neurodegenerative disorder. The diagnosis of PD is challenging and currently none of the biochemical tests have proven to help in diagnosis. Serum metallomic analysis may suggest the possibility of diagnosis of PD.

Methodology/Results

The metallomic analysis was targeted on 31 elements obtained from 42 healthy controls and 45 drug naive PD patients using ICP-AES and ICP-MS to determine the concentration variations of elements between PD and normal. The targeted metallomic analysis showed the significant variations in 19 elements of patients compared to healthy control (p<0.04). The partial least squares discriminant analysis (PLS-DA) showed aluminium, copper, iron, manganese and zinc are the key elements, contributes the separation of PD patients from control samples. The correlation coefficient analysis and element-element ratio confirm the imbalance of inter-elements relationship in PD patients'' serum. Furthermore, elements linkage map analysis showed aluminium is a key element involved in triggering of phosphorus, which subsequently lead to imbalance of homeostatic in PD serum. The execution of neural network using elements concentrations provides 95% accuracy in detection of disease.

Conclusions/Significance

These results suggest that there is a disturbance in the elements homeostasis and inter-elements relationship in PD patients'' serum. The analysis of serum elements helps in linking the underlying cellular processes such as oxidative stress, neuronal dysfunction and apoptosis, which are the dominating factors in PD. Also, these results increase the prospect of detection of early PD from serum through neural network algorithm.